NASDAQ:ANPC
Delisted
AnPac Bio-Medical Science Co., Ltd. Stock News
$4.37
+0 (+0%)
At Close: Aug 18, 2023
AnPac Bio Launches New Immunology Test Product Line
12:46pm, Monday, 22'nd Jun 2020
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening an
AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening
12:00pm, Friday, 19'th Jun 2020
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening an
Tiger Asia Intelligence reiterate Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC)
08:20pm, Wednesday, 10'th Jun 2020
The full report can be found here: AnPac Report
The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study
11:39am, Wednesday, 03'rd Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) * Agenus Inc (NASDAQ: AGEN)(announced FDA clearance of
AnPac Bio Announces Appointment of New Chief Financial Officer
09:00pm, Tuesday, 02'nd Jun 2020
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening an
Adult-Use Cannabis Sales Resume In Massachusetts | Ganjapreneur
03:31pm, Tuesday, 26'th May 2020
Recreational cannabis sales have been restarted in Massachusetts after being shuttered by Gov. Charlie Baker (R) in late March as… Read More
AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States
12:00pm, Tuesday, 26'th May 2020
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening an
AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019
12:30pm, Monday, 18'th May 2020
Continued annual revenue growthNumber of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-yearContinued to gain customers and increase the.
AnPac Files Its Annual Report on Form 20-F
12:24pm, Monday, 18'th May 2020
The Company's annual report on Form 20-F, which contains its audited consolidated financial statements, can be accessed on and downloaded from the SEC's website at www.sec.gov as well as on the Compan
AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States
10:46am, Monday, 11'th May 2020
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening an
ANPC: A Blood Test for Cancer Diagnosis
01:15pm, Thursday, 30'th Apr 2020
NASDAQ:ANPC AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) was founded in 2010 by an inventor in the semiconductor technology industry and an expert in molecular epidemiology and cancer research. T
ANPC: A Blood Test for Cancer Diagnosis
09:00am, Thursday, 30'th Apr 2020
NASDAQ:ANPC AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) was founded in 2010 by an inventor in the semiconductor technology industry and an expert in molecular epidemiology and cancer research. T
Head to Head Review: Anpac Bio-Medical Science (NASDAQ:ANPC) versus CareDx (NASDAQ:CDNA)
05:22am, Sunday, 26'th Apr 2020
Anpac Bio-Medical Science (NASDAQ:ANPC) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of thei
Comparing Anpac Bio-Medical Science (NASDAQ:ANPC) and Quest Diagnostics (NASDAQ:DGX)
06:34am, Friday, 24'th Apr 2020
Anpac Bio-Medical Science (NASDAQ:ANPC) and Quest Diagnostics (NYSE:DGX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their
Tiger Asia Intelligence Initiates Coverage on AnPac Bio, Ltd
12:30pm, Monday, 30'th Mar 2020
Tiger Asia Intelligence has announced it has initiated coverage on AnPac Bio, Ltd (NASDAQ: ANPC).
